跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Zefei
Approved
STANDARD
Zefei
Jiangsu Hansoh Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f562667dabd4ca0b
Company
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
f562667dabd4ca0b
Drug Approval Philippines Name
Zefei
Product Name
Zefei
Registration Number
DR-XY33193
Brand Name
Zefei
Generic Name
Gemcitabine (as hydrochloride)
Dosage Form
Lyophilized Powder for Solution for Infusion (IV)
Dosage Strength
200 mg
Manufacturer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Importer
Goodfellow Pharma Corporation
Distributor
Goodfellow Pharma Corporation
Issuance Date
25 July 2022
Expiry Date
25 July 2027
Pharmacologic Category
Antineoplastic (Pyrimidine analogue)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f562667dabd4ca0b
Type
Standard
Back to Philippines FDA Approvals
Zefei - Philippines FDA Drug Approval Details